TYROBP and tauopathy: In our previous studies, deletion of Tyrobp (also known as DAP12) in AD amyloidopathy and tauopathy mouse models mitigates cognitive dysfunction and restores synaptic function, while decreasing microglial clustering around amyloid plaques [28–30].